Alemany-Cosme, E., Cruz-Chamorro, D., Hervas, D., Garcia, D., Martinez-Tomas, R., Briones-Gomez, A., . . . Sandoval, J. (2025). Genome-wide methylation analysis of circulating cell-free DNA identifies an episignature in lung cancer: Validation of EMP2 as a potential biomarker.
Citación estilo ChicagoAlemany-Cosme, E., et al. Genome-wide Methylation Analysis of Circulating Cell-free DNA Identifies an Episignature in Lung Cancer: Validation of EMP2 As a Potential Biomarker. 2025.
Cita MLAAlemany-Cosme, E., et al. Genome-wide Methylation Analysis of Circulating Cell-free DNA Identifies an Episignature in Lung Cancer: Validation of EMP2 As a Potential Biomarker. 2025.
Precaución: Estas citas no son 100% exactas.